Moscow will act with the winner of the US election

The head of Russia’s sovereign wealth fund told CNBC that US-Russia relations were at an all-time low.

Russia has not yet officially acknowledged the election of Democrat Joe Biden as US president, but has said it will do so only after the official decision is confirmed, given the legal battles initiated by current President Donald Trump and the possibility of multiple votes. Recounts. While Trump refuses to acknowledge, Biden goes on to say that his change plan is “an embarrassment” that Trump has no concessions.

However, the head of the RTIF (Russian Direct Investment Fund), Grill Dmitriev, reiterated comments from the Kremlin earlier this week that Russia should “finally count the votes” before recognizing the winner of the election.

“Russia will work with the elected president of the United States. We are at a very low ebb in US – Russia relations. We want to improve them, so we will work with anyone who wants to work with Russia. It is very important for other parts of the world to improve that relationship,” Dmitriev told CNBC’s Capital Link on Thursday.

US pharmaceutical company Pfizer and German biotech Bioendech announced on Monday that the corona virus vaccine would be released soon, following the announcement that their Covit-19 vaccine candidate was more than 90% effective. When hopes were raised Moderna announced Wednesday evening Its Govt vaccine phase three trials have yielded enough cases of the corona virus to submit preliminary results to an independent safety watchdog.

Meanwhile, Russia, the world’s first country to register for the corona virus vaccine in August, announced on Wednesday that its corona virus vaccine was 92% effective in preventing people from getting COV-19. Based on interim test results.

RTIF, which supports the development and distribution of the vaccine, evaluated its effectiveness among more than 16,000 volunteers who received the vaccine or placebo 21 days after the first injection (such as the Pfizer vaccine, which includes two separate doses in Russia). The trial of 20 confirmed cases of corona virus among participants reached conclusions about the effectiveness of the vaccine..

In comparison, the Pfizer / Bioentech analysis was based on 94 confirmed Govt-19 infections in 43,538 participants of its trial. Because vaccine or placebo recipients are currently showing the presence of the virus, a test target should attack the infection before the data can be released.

The RTIF said Russia’s interim test results would be published in “one of the leading internationally reviewed medical journals”, but did not specify when.

An analysis of 20 confirmed Govt cases where the sample size was so small, Dmitriev of the RDIF said that this number was commanded when the first interim data “checkpoint” was triggered by the medical protocol.

“We are very cautious and optimistic about the data,” Dmitriev told CNBC. “It’s more important to talk data than to talk Russia.”

The next checkpoint on the effectiveness of the infection – 39 infected people will be analyzed.

“So we will post to the world, but we believe this is definitely the best data, because even 50% performance is considered good. And anything above 90% is better,” he said.

“We are very excited about the Pfizer results. We know the Moderna results will be out soon. We want all vaccines to be successful. The world needs successful vaccines.”

– CNBC’s Abigail NG reported the story.